Cyclo(RGDyK) trifluoroacetate
CAS: 250612-42-1
Ref. 3D-AKA61242
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Cyclo(RGDyK) trifluoroacetate
Descripción:
Cyclo(RGDyK) trifluoroacetate is a cilengitide that has been shown to inhibit tumor growth in xenografts. It binds to the cancer cell surface and inhibits the formation of heterodimers between integrin αvβ3 and its ligand, vitronectin. The inhibition of these heterodimer formation leads to an inhibitory effect on tumor angiogenesis. Cyclo(RGDyK) trifluoroacetate has been shown to have a high uptake in human serum, tissues, and tumors. This drug also has pharmacokinetic properties and molecular modeling studies have shown that it can be conjugated with positron-emitting isotopes for imaging. Cyclo(RGDyK) trifluoroacetate is taken up by MCP-7 cells at a higher rate than other cells due to its RGD sequence.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
847.72 g/mol
Fórmula:
C31H43F6N9O12
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
